Pulmonology Articles

Pulmonology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Donnelly L et al. – LABA may inhibit inflammatory cytokine release from macrophages in a cAMP–independent manner and act additively with budesonide.


Related Articles

Skin thickness in children treated with daily or periodical inhaled budesonide for mild persistent asthma
Pediatric Research, 10/29/09    Relevance Score: 88%

Budesonide/formoterol effects on metalloproteolytic balance in TGF-beta-activated human lung fibroblasts
Respiratory Medicine, 10/13/09    Relevance Score: 88%

Budesonide/formoterol maintenance and reliever therapy versus conventional best practice
Respiratory Medicine, 10/13/09    Relevance Score: 87%

Safety of budesonide/formoterol maintenance and reliever therapy in asthma trials
Respiratory Medicine, 11/18/09    Relevance Score: 83%

Budesonide/formoterol pressurized metered-dose inhaler: a guide to its use in asthma
Drugs & Therapy Perspectives, 10/16/09    Relevance Score: 83%

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address